Small Pharma Inc.
DMTTF · OTC
2/28/2023 | 2/28/2022 | 2/28/2021 | 2/29/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $19 | $41 | $6 | $1 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $1 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $0 | $0 | $0 | $0 |
| Total Curr. Assets | $20 | $43 | $7 | $1 |
| Property Plant & Equip (Net) | $1 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $0 | $3 | $0 | $0 |
| Total NC Assets | $1 | $3 | $0 | $0 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $21 | $46 | $7 | $1 |
| Liabilities | – | – | – | – |
| Payables | $0 | $0 | $0 | $0 |
| Short-Term Debt | $0 | $0 | $9 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $3 | $3 | -$4 | $0 |
| Total Curr. Liab. | $4 | $4 | $12 | $0 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | -$0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $4 | $4 | $12 | $0 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $70 | $70 | $3 | $3 |
| Retained Earnings | -$55 | -$32 | -$9 | -$2 |
| AOCI | -$2 | -$0 | -$0 | -$0 |
| Other Equity | $4 | $3 | $47 | $0 |
| Total Equity | $17 | $41 | -$6 | $1 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $21 | $46 | $7 | $1 |
| Net Debt | -$18 | -$40 | $3 | -$1 |